Cytokine storm: When the immune system goes into overdrive

1 Introduction

Cytokine storm is a severe immune system reaction that occurs when the body’s immune system overreacts to an infection, injury, or disease, and releases large amounts of cytokines into the bloodstream [1]. Cytokines are proteins that play a crucial role in regulating the immune response to infections and other stimuli. When the immune system detects an infection, it activates immune cells to attack the invading pathogen. In response, these immune cells release cytokines, which signal other immune cells to join the attack. However, in some cases, the immune response can become too intense, and the immune cells release excessive amounts of cytokines, leading to a cytokine storm [2]. The cytokines cause widespread inflammation throughout the body, which can damage tissues and organs and lead to life-threatening complications such as acute respiratory distress syndrome (ARDS), multiple organ failure, and even death. Cytokine storm is associated with several diseases, including sepsis, influenza, COVID-19, and autoimmune disorders such as rheumatoid arthritis and lupus [3].

2 Clinical features of cytokine storm

The clinical features of cytokine storm can vary depending on the underlying cause, but some common symptoms and signs include: The release of cytokines can cause a rapid rise in body temperature, leading to a high fever. Patients may experience fatigue, weakness, and loss of energy. Cytokine storm can lead to acute respiratory distress syndrome (ARDS), a severe lung condition that causes difficulty breathing and can require mechanical ventilation. Cytokine storm can cause a drop in blood pressure, which can lead to shock and organ damage. The widespread inflammation caused by cytokine storm can damage organs such as the liver, kidneys, and heart, leading to organ failure. Patients may develop a rash or other skin changes. Cytokine storm can cause joint pain and swelling in some patients. It is important to note that not all patients with cytokine storm will present with all of these symptoms, and some patients may have other clinical features specific to the underlying cause of the condition [4].

3 Laboratory abnormalities in cytokine storm

Laboratory abnormalities in cytokine storm can also vary depending on the underlying cause, but some common findings include: Elevated cytokine levels: Patients with cytokine storm typically have elevated levels of cytokines such as interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor-alpha (TNF-alpha) in their blood. Elevated inflammatory markers: Patients may have elevated levels of acute-phase reactants such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are markers of inflammation. Abnormal blood cell counts: Patients may have low levels of white blood cells, including lymphocytes and neutrophils, which are important immune cells. Platelet counts may also be low. Liver and kidney function tests: Cytokine storm can cause liver and kidney damage, and patients may have elevated liver enzymes (AST and ALT) and creatinine levels. Coagulation abnormalities: Patients with cytokine storm may have abnormal blood clotting, which can lead to disseminated intravascular coagulation (DIC) and thrombosis. It is important to note that laboratory abnormalities can be non-specific and vary depending on the underlying cause of cytokine storm. Therefore, clinical correlation and careful evaluation of the patient’s medical history and physical examination findings are critical for accurate diagnosis and management [5].

4 Types of cytokine storm

There are several types of cytokine storm, which can be broadly categorized into primary and secondary cytokine storms. Primary cytokine storm: This type of cytokine storm is caused by a genetic mutation or a primary immune system disorder, such as macrophage activation syndrome (MAS), hemophagocytic lymphohistiocytosis (HLH), or familial Mediterranean fever (FMF). Secondary cytokine storm: This type of cytokine storm is triggered by an external stimulus, such as an infection, autoimmune disease, or cancer. Secondary cytokine storms are more common than primary cytokine storms and are associated with a wide range of conditions, including sepsis, influenza, COVID-19, and autoimmune disorders such as rheumatoid arthritis and lupus. In addition to these broad categories, cytokine storms can also be classified based on the specific cytokines involved, such as IL-6 storm or TNF-alpha storm. Each type of cytokine storm can have unique clinical features and treatment considerations, and early recognition and management are critical for improving patient outcomes [6].

5 COVID 19 induced cytokine storm

COVID-19 induced cytokine storm, also known as “cytokine release syndrome” or “hyperinflammatory response,” is a severe immune reaction that can occur in some patients with COVID-19. The SARS-CoV-2 virus that causes COVID-19 can trigger an intense immune response in some patients, causing immune cells to release excessive amounts of cytokines into the bloodstream. This can lead to a cytokine storm, which can cause widespread inflammation, tissue damage, and multiple organ failure. COVID-19-induced cytokine storm is characterized by elevated levels of cytokines, including interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor-alpha (TNF-alpha) [7, 8]. Patients with severe COVID-19 may experience symptoms such as fever, fatigue, cough, shortness of breath, and low blood oxygen levels. In some cases, the cytokine storm can lead to acute respiratory distress syndrome (ARDS), septic shock, and other life-threatening complications. Treatment for COVID-19-induced cytokine storm may include anti-inflammatory medications such as corticosteroids, interleukin-6 inhibitors, and other immune-modulating therapies. Oxygen therapy, mechanical ventilation, and other supportive care measures may also be necessary. Early recognition and management of cytokine storm in COVID-19 patients are critical for improving outcomes and reducing mortality [9].

Thrombotic events, which refer to the formation of blood clots in blood vessels, have been observed in some COVID-19 patients, particularly those who are severely ill. One possible explanation for the increased risk of thrombotic events in COVID-19 patients is the cytokine storm, which is an overreaction of the immune system that can occur in some patients with severe COVID-19 [10, 11]. During a cytokine storm, the immune system releases large amounts of cytokines, which are signaling molecules that help to coordinate the immune response. However, when cytokines are produced in excess, they can cause damage to the body’s tissues and organs, including the lining of blood vessels. This can lead to the formation of blood clots, as well as inflammation and damage to the affected organs. Furthermore, COVID-19 can also directly damage blood vessels, leading to endothelial dysfunction and activation of blood coagulation. The virus has been shown to infect endothelial cells and cause injury to the vascular endothelium, which can further increase the risk of thrombotic events [12].

6 Treatment strategies for cytokine storm

The treatment of cytokine storm depends on the underlying cause and severity of the condition. However, some common treatment strategies for cytokine storm include: Immunosuppressive therapy: Immunosuppressive medications such as corticosteroids, cyclosporine, and other immune-modulating agents can help reduce the immune response and cytokine production. Cytokine inhibitors: Drugs that target specific cytokines such as interleukin-6 (IL-6) or tumor necrosis factor-alpha (TNF-alpha) can be effective in reducing cytokine levels and improving patient outcomes. Supportive care: Patients with cytokine storm may require oxygen therapy, mechanical ventilation, and other supportive care measures to maintain organ function and manage complications such as septic shock. Plasma exchange or plasmapheresis: These procedures involve removing plasma from the patient’s blood and replacing it with donor plasma or other replacement fluids to remove harmful cytokines from circulation. Other therapies: Other treatments that have been used for cytokine storm include intravenous immunoglobulin (IVIG), extracorporeal membrane oxygenation (ECMO), and Janus kinase (JAK) inhibitors. It is important to note that treatment for cytokine storm should be tailored to the individual patient’s needs and underlying condition, and early recognition and management are critical for improving outcomes [13].

7 Cytokine inhibitors in cytokine storm

Cytokine inhibitors are a class of drugs that target specific cytokines involved in the cytokine storm. Cytokine inhibitors work by blocking the activity of these cytokines, which can help reduce inflammation and prevent tissue damage. Some examples of cytokine inhibitors used in the treatment of cytokine storm include Tocilizumab is a monoclonal antibody that targets interleukin-6 (IL-6), which is a cytokine that is often elevated in cytokine storm. Tocilizumab has been used in the treatment of cytokine storm associated with COVID-19, as well as other conditions such as rheumatoid arthritis. Anakinra: Anakinra is an interleukin-1 (IL-1) receptor antagonist that blocks the activity of IL-1, which is another cytokine that can be elevated in cytokine storm [14]. Anakinra has been used in the treatment of cytokine storm associated with sepsis and other inflammatory conditions. Emapalumab: Emapalumab is a monoclonal antibody that targets interferon-gamma (IFN-gamma), which is a cytokine that can be elevated in primary cytokine storm syndromes such as hemophagocytic lymphohistiocytosis (HLH). Emapalumab has been approved for the treatment of primary HLH [15–17]. Sarilumab: Sarilumab is a monoclonal antibody that targets the IL-6 receptor and has been used in the treatment of cytokine storm associated with COVID-19 [18, 19]. Baricitinib: Baricitinib is a Janus kinase (JAK) inhibitor that can block signaling pathways involved in the cytokine storm. Baricitinib has been used in combination with remdesivir for the treatment of COVID-19 [20, 21].

8 Conclusion

In conclusion, cytokine storm is a complex immune response that can occur in various medical conditions and can lead to severe morbidity and mortality. The excessive release of cytokines causes widespread inflammation and tissue damage, leading to organ dysfunction and failure. The treatment of cytokine storm is often challenging and involves a multidisciplinary approach that includes immunosuppressive therapy, cytokine inhibitors, supportive care, plasma exchange, and other therapies. Further research is needed to better understand the pathophysiology of cytokine storm and develop more effective treatment strategies.